← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2011Last known activity
Aug 12, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 11 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT07180108CollaboratorPhase 1Aug 12, 2025
- NCT06644170CollaboratorPhase 1Dec 1, 2024
- NCT06611111CollaboratorEarly Phase 1Nov 30, 2024
- NCT05837845CollaboratorPhase 2Feb 29, 2024
- NCT05961527CollaboratorPhase 1/Phase 2Oct 1, 2023
- NCT05847686CollaboratorPhase 1/Phase 2Jun 27, 2023
- NCT05370911CollaboratorPhase 1Feb 28, 2023
- NCT05305105CollaboratorPhase 1Jul 1, 2022
- NCT04982796CollaboratorPhase 1/Phase 2Jan 15, 2022
- NCT01590628Overall official - principal investigatorPhase 1/Phase 2Apr 1, 2012
- NCT01425307CollaboratorPhase 3Aug 1, 2011
Details
- Last known activity
- Aug 12, 2025